- 全部删除
您的购物车当前为空
PARP1-IN-5 dihydrochloride 是一种具有口服活性的有效选择性 PARP-1 抑制剂 (IC50 =14.7 nM)。它可用于癌症的研究。

PARP1-IN-5 dihydrochloride 是一种具有口服活性的有效选择性 PARP-1 抑制剂 (IC50 =14.7 nM)。它可用于癌症的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 860 | In stock | |
| 5 mg | ¥ 1,950 | In stock | |
| 10 mg | ¥ 3,150 | In stock | |
| 25 mg | ¥ 4,970 | In stock | |
| 50 mg | ¥ 6,990 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,450 | In stock |
PARP1-IN-5 dihydrochloride 相关产品
| 产品描述 | PARP1-IN-5 dihydrochloride is an orally active, potent and selective PARP-1 inhibitor (IC50 =14.7 nM). PARP1-IN-5 dihydrochloride can be used for the research of cancer. |
| 靶点活性 | PARP2:0.9 μM, PARP1:14.7 nM |
| 体外活性 | PARP1-IN-5 dihydrochloride 在0.1~10μM浓度范围内能显著增强CBP对A549细胞的细胞毒性,表现出剂量依赖性。同时,PARP1-IN-5 dihydrochloride 能降低SK-OV-3细胞中MCM2-7的表达。在0.1~320μM的浓度下,PARP1-IN-5 dihydrochloride 对A549细胞的细胞毒性效应较弱。它能显著降低SK-OV-3细胞上的PAR水平。PARP1-IN-5 dihydrochloride 通过PARP-1发挥抗肿瘤作用,并能增加γ-H2AX的表达。 |
| 体内活性 | PARP1-IN-5 dihydrochloride (1000 mg/kg;口服)显示体重和血常规[1]没有显著差异。PARP1-IN-5 dihydrochloride (25和50 mg/kg;口服;12天)在50 mg/kg时显著增强了卡铂对A549细胞的抑制效果[1]。PARP1-IN-5 dihydrochloride (50 mg/kg;口服)与PARP-1表达量正相关[1]。PARP1-IN-5 dihydrochloride 能降低PAR表达,并上调γ-H2AX表达[1]。 |
| 分子量 | 537.46 |
| 分子式 | C25H26Cl2N2O5S |
| CAS No. | 2823308-89-8 |
| Smiles | O=C1C=C(C2=CC=C(O)C=C2)OC3=C(CN4CCN(CC5=CC=CS5)CC4)C(O)=CC(O)=C31.Cl[H].Cl[H] |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 125 mg/mL (232.58 mM), Sonication is recommended. H2O: 1 mg/mL (1.86 mM), Sonication and heating to 60℃ are recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容